Darin Lippoldt, Chief Legal Officer at Neurocrine Biosciences Inc. ($NBIX), made one open market sale of shares in the last year, totaling about $699,000. His most recent sale occurred on December 8, 2025. This ranks him 5,745th out of 11,678 insiders by sale value, well below the average of $8.6 million across roughly 6.4 transactions. Lippoldt recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 967 | $123.10 | 48,617.0000 | 102,500,000 | 1.95% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | G | Common Stock | 365 | $0.00 | 54,729.0000 | 102,500,000 | 0.66% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 5378 | $124.12 | 55,094.0000 | 102,500,000 | 8.89% | 0.01% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | A | Common Stock | 9968 | $0.00 | 60,472.0000 | 102,500,000 | 19.74% | 0.01% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 1124 | $124.12 | 50,504.0000 | 102,500,000 | 2.18% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2083 | $0.00 | 51,628.0000 | 102,500,000 | 4.20% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 1089 | $124.12 | 49,545.0000 | 102,500,000 | 2.15% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2017 | $0.00 | 50,634.0000 | 102,500,000 | 4.15% | 0.00% |
| Feb. 12, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 1792 | $0.00 | 49,584.0000 | 102,500,000 | 3.75% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | A | Restricted Stock Unit | 6124 | $0.00 | 6,124.0000 | 102,500,000 | 9999.99% | 0.01% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | A | Stock Option | 34909 | $0.00 | 34,909.0000 | 102,500,000 | 9999.99% | 0.03% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2083 | $0.00 | 2,083.0000 | 102,500,000 | 50.00% | 0.00% |
| Feb. 13, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2017 | $0.00 | 4,036.0000 | 102,500,000 | 33.32% | 0.00% |
| Feb. 12, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 1792 | $0.00 | 5,377.0000 | 102,500,000 | 25.00% | 0.00% |
| Jan. 31, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2373 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 31, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | F | Common Stock | 1335 | $136.06 | 47,792.0000 | 102,500,000 | 2.72% | 0.00% |
| Jan. 31, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2373 | $0.00 | 49,127.0000 | 102,500,000 | 5.08% | 0.00% |
| Jan. 8, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Incentive Stock Option | 3349 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Jan. 8, 2026 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 3349 | $35.99 | 46,754.0000 | 102,500,000 | 7.72% | 0.00% |
| Dec. 8, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 4376 | $0.00 | 0.0000 | 102,500,000 | 100.00% | 0.00% |
| Dec. 8, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 4376 | $159.65 | 43,405.0000 | 102,500,000 | 9.16% | 0.00% |
| Dec. 8, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 4376 | $43.24 | 47,781.0000 | 102,500,000 | 10.08% | 0.00% |
| Feb. 12, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | G | Common Stock | 190 | $0.00 | 41,489.0000 | 103,700,000 | 0.46% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2083 | $0.00 | 43,572.0000 | 103,700,000 | 5.02% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1098 | $116.76 | 42,474.0000 | 103,700,000 | 2.52% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2017 | $0.00 | 44,491.0000 | 103,700,000 | 4.75% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1086 | $116.75 | 43,405.0000 | 103,700,000 | 2.44% | 0.00% |
| Feb. 12, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | A | Stock Option | 38252 | $0.00 | 38,252.0000 | 103,700,000 | 9999.99% | 0.04% |
| Feb. 12, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | A | Restricted Stock Unit | 7169 | $0.00 | 7,169.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2083 | $0.00 | 4,166.0000 | 103,700,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2017 | $0.00 | 6,053.0000 | 103,700,000 | 24.99% | 0.00% |
| Feb. 8, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 1727 | $0.00 | 42,590.0000 | 103,700,000 | 4.23% | 0.00% |
| Feb. 10, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 911 | $118.25 | 41,679.0000 | 103,700,000 | 2.14% | 0.00% |
| Feb. 8, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 1727 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Jan. 31, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Restricted Stock Unit | 2373 | $0.00 | 2,373.0000 | 103,700,000 | 50.00% | 0.00% |
| Jan. 31, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2373 | $0.00 | 42,113.0000 | 103,700,000 | 5.97% | 0.00% |
| Jan. 31, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1250 | $152.91 | 40,863.0000 | 103,700,000 | 2.97% | 0.00% |
| Aug. 1, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 2996 | $154.01 | 39,740.0000 | 101,000,000 | 7.01% | 0.00% |
| Aug. 1, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 2996 | $79.02 | 42,736.0000 | 101,000,000 | 7.54% | 0.00% |
| Aug. 1, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 2996 | $0.00 | 43,372.0000 | 101,000,000 | 6.46% | 0.00% |
| July 16, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 7004 | $150.00 | 39,740.0000 | 101,000,000 | 14.98% | 0.01% |
| July 16, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 7004 | $79.02 | 46,744.0000 | 101,000,000 | 17.62% | 0.01% |
| July 16, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 7004 | $0.00 | 46,368.0000 | 101,000,000 | 13.12% | 0.01% |
| Feb. 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | A | Stock Option | 40552 | $0.00 | 40,552.0000 | 101,000,000 | 9999.99% | 0.04% |
| Feb. 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1098 | $132.99 | 39,740.0000 | 101,000,000 | 2.69% | 0.00% |
| Feb. 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | A | Restricted Stock Unit | 8070 | $0.00 | 8,070.0000 | 101,000,000 | 9999.99% | 0.01% |
| Feb. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 911 | $134.24 | 38,755.0000 | 101,000,000 | 2.30% | 0.00% |
| Feb. 6, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1041 | $142.17 | 37,939.0000 | 101,000,000 | 2.67% | 0.00% |
| Jan. 31, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1250 | $140.65 | 37,005.0000 | 101,000,000 | 3.27% | 0.00% |
| Jan. 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 10000 | $79.02 | 53,372.0000 | 101,000,000 | 15.78% | 0.01% |
| Jan. 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 10000 | $79.02 | 45,882.0000 | 101,000,000 | 27.87% | 0.01% |
| Jan. 22, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 10000 | $139.86 | 35,882.0000 | 101,000,000 | 21.80% | 0.01% |
| Dec. 6, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 20830 | $119.86 | 35,882.0000 | 98,900,000 | 36.73% | 0.02% |
| Dec. 6, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Non-Qualified Stock Option | 20830 | $43.24 | 4,376.0000 | 98,900,000 | 82.64% | 0.02% |
| Dec. 6, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | M | Common Stock | 20830 | $43.24 | 56,712.0000 | 98,900,000 | 58.05% | 0.02% |
| Nov. 27, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 10919 | $112.27 | 35,882.0000 | 98,900,000 | 23.33% | 0.01% |
| Aug. 30, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | G | Common Stock | 190 | $0.00 | 46,801.0000 | 98,900,000 | 0.40% | 0.00% |
| Aug. 21, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 2132 | $107.39 | 46,991.0000 | 98,900,000 | 4.34% | 0.00% |
| Feb. 13, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | A | Stock Option | 51782 | $0.00 | 51,782.0000 | 98,900,000 | 9999.99% | 0.05% |
| Feb. 13, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | A | Restricted Stock Unit | 8332 | $0.00 | 8,332.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 8, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 911 | $104.08 | 44,973.0000 | 98,900,000 | 1.99% | 0.00% |
| Feb. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 12801 | $102.42 | 44,157.0000 | 98,900,000 | 22.47% | 0.01% |
| Feb. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1522 | $102.24 | 32,660.0000 | 98,900,000 | 4.45% | 0.00% |
| Feb. 6, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1041 | $105.80 | 31,290.0000 | 98,900,000 | 3.22% | 0.00% |
| Jan. 31, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | Lippoldt Darin | Chief Legal Officer | S | Common Stock | 1250 | $109.97 | 30,357.0000 | 98,900,000 | 3.95% | 0.00% |